Quick Takeaways
- This page summarizes George Peoples's Form 4 filing for Calidi Biotherapeutics, Inc. (CLDI).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 11 Jul 2024, 16:53.
George Peoples - 01 Jul 2024 Form 4 Insider Report for Calidi Biotherapeutics, Inc. (CLDI)
- Role
- Director
- Signature
- /s/ Andrew Jackson, Attorney-in-fact
- Issuer symbol
- CLDI
- Transactions as of
- 01 Jul 2024
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 11 Jul 2024, 16:53:47 UTC
- Next filing
- 15 Oct 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"George Peoples filed Form 4 for Calidi Biotherapeutics, Inc. (CLDI) on 11 Jul 2024."
What Changed
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLDI | Non-Qualified Stock Options (right to buy) | Award | +30,904 | 30,904 | 01 Jul 2024 | Common stock | 30,904 | $0.1930 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Pursuant to the Issuer's 2023 Equity Incentive Plan (the "2023 Plan"), on July 1, 2024 (the "Grant Date"), the Reporting Person was granted 30,904 non-qualified stock options (the "Options") at the exercise price of $0.193, which is the closing price of the Issuer's common stock on the Grant Date. The Options shall vest in 1/36 per month over three years, commencing on the Grant Date. |
Remarks:
Exhibit 24 - Power of Attorney (previously filed as Exhibit 24 to Form 3 dated July 8, 2024.)